Arabic Arabic English English French French German German
dark

BioTheryX Announces Expansion of Scientific Advisory Board with Appointment of Brenda Schulman

 BioTheryX, Inc., a clinical-stage company focused on degrading proteins to create life-saving medicines, today announced the expansion of its Scientific Advisory Board (SAB) with the appointment of Brenda Schulman , Ph.D., Director of the Department of Molecular Machines and Signaling at Max Planck Institute of Biochemistry, Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Idera Pharmaceuticals Announces Corporate Updates

Next Post

Agilex Biolabs’ Toxicology Tapped for SARS-CoV-2 Vaccine Research

Related Posts
Total
0
Share